AMC updates

in page functions
1 - 8 of 8 matches Page: 1 

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

10 September 2010

Pfizer vaccine receives AMC approval

The AMC Secretariat announces that the Independent Assessment Committee of the Advance Market Commitment (AMC) for pneumococcal disease has approved Pfizer's pneumococcal vaccine Prevenar 13, as eligible for purchase to the AMC terms and conditions.

04 March 2010

Conference on Innovative Financial Solutions for Development

IFFIm and AMC are considered the "most encouraging" examples of innovative thinking in development at the Marketplace for Innovative Financial Solutions in Paris.

12 October 2009

Pneumococcal AMC receives offers

The AMC Secretariat announces four suppliers have made offers to supply vaccines under the Pneumococcal Advance Market Commitment.

30 September 2009

New registered manufacturer is publicly announced

With the June launch of the pilot AMC against pneumococcal disease, manufacturers are now registering to participate Panacea Biotect Ltd and the Serum institute of India are two of the companies that have begun the registration process in order to partici

23 September 2009

Manufacturers register to participate in the Pneumococcal AMC

With the June launch of the pilot AMC against pneumococcal disease, manufacturers are now registering to participate.

 

12 June 2009

GAVI partners fulfil promise

The GAVI Alliance partners, the World Bank, WHO and UNICEF, and five national governments and the Bill & Melinda Gates Foundation today formally kicked-off the first-ever Advance Market Commitment (AMC) designed to accelerate access to vaccines against pneumococcal disease.

01 June 2008

Pilot AMC for pneumococcal disease

To accelerate the development and availability of new vaccines against pneumococcal disease, Italy, the UK, Canada, Norway, Russia, and the Bill & Melinda Gates Foundation together committed US$ 1.5 billion to finance a pilot Advance Market Commitment (AMC).

01 May 2008

Optimal terms for a pilot AMC

Input from developing countries, industry, civil society organisations and donors are being considered in determining the optimal terms for a pilot AMC.




close icon

modal window here